Predicting risk of death from cardiovascular disease. Which measurements are the most appropriate?

Comment

M J White. BMJ. 2001.

. 2001 Oct 27;323(7319):999; author reply 1000.

No abstract available

Comment on

Nonspecific medication side effects and the nocebo phenomenon.
Barsky AJ, Saintfort R, Rogers MP, Borus JF. Barsky AJ, et al. JAMA. 2002 Feb 6;287(5):622-7. doi: 10.1001/jama.287.5.622. JAMA. 2002. PMID: 11829702 Review.

1. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. A score for prediction risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001;323:75–81. . (14 July.) - PMC - PubMed
1. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. A score for prediction risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001;323:75–81. . (14 July.) - PMC - PubMed
1. Randolph AG, Guyatt GH, Calvin JE, Doig G, Richardson WS. Understanding articles describing clinical prediction tools. Evidence Based Medicine in Critical Care Group. Crit Care Med. 1998;26:1603–1612. - PubMed
1. Ruttimann UE. Statistical approaches to development and validation of predictive instruments. Crit Care Clin. 1994;10:19–36. - PubMed
1. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. A score for prediction risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001;323:75–81. . (14 July.) - PMC - PubMed